Kaufman Michael J. 4
4 · Mersana Therapeutics, Inc. · Filed Jan 20, 2021
Insider Transaction Report
Form 4
Kaufman Michael J.
Sr VP Chmistry, Man & Control
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-01-15−6,667→ 20,000 total→ Common Stock (6,667 underlying) - Award
Stock Option (right to buy)
2021-01-15+112,500→ 112,500 totalExercise: $21.09Exp: 2031-01-15→ Common Stock (112,500 underlying) - Award
Restricted Stock Units
2021-01-15+25,000→ 25,000 total→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2021-01-15+6,667→ 6,667 total - Tax Payment
Common Stock
2021-01-15$21.09/sh−1,957$41,273→ 4,710 total
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.
- [F2]Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F3]25% of the total number of RSUs vested on January 15, 2021, and thereafter shall vest in equal annual installments over the next three years.
- [F4]The option vests in equal quarterly installments over the first four years after the vesting commencement date, January 15, 2021.
- [F5]The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 15, 2021.